We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
46 hedge funds and large institutions have $28.2M invested in Fate Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
46% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less funds holding
Funds holding: 54 → 46 (-8)
55% less capital invested
Capital invested by funds: $62.7M → $28.2M (-$34.5M)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
46
Holders Change
-8
Holders Change %
-14.81%
% of All Funds
1.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
19
Reduced
13
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.4M |
| 2 |
BC
Broadfin Capital
New York
|
-$3.75M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$1.82M |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$697K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$569K |
